$14.38
Currently 23 wall-street analysts regularly analyze the financials of Denali Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Denali Therapeutics Inc (DNLI) have a share price target of $32.31. This median of share price forecast represents a 124.7% upside from the latest price of $14.38 as on 11.05.25.
As per the chart shown above, analysts believe that the Denali Therapeutics Inc (DNLI) share price will touch around $32.31 in next 12-months.
Below is a chart showing the percentage difference between Denali Therapeutics Inc's share price and its median forecast price. As on 11.05.25, the difference is -50.3%
Based on 23 analysts tracking and researching Denali Therapeutics Inc (DNLI) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 11 | 11 | 11 |
Outperform | 9 | 9 | 9 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |